Let Them Eat During Dialysis: An Overlooked Opportunity to Improve Outcomes in Maintenance Hemodialysis Patients

Journal of Renal Nutrition

Volumn 23, Issue 3, 2013, Pages 157-163

  Kalantar Zadeh, Kamyar ^a,b   Ikizler, T Alp ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN;

CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; DIET THERAPY; ECONOMICS; HUMAN; HYPOALBUMINEMIA; MEAL; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PATHOPHYSIOLOGY; PROTEIN CALORIE MALNUTRITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW;

DIETARY SUPPLEMENTS; HUMANS; HYPOALBUMINEMIA; MEALS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PROTEIN-ENERGY MALNUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SERUM ALBUMIN;

EID: 84876726087     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2012.11.001     Document Type: Review

References (62)

1. Pupim L.B., Caglar K., Hakim R.M., et al. Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int 2004, 66:2054-2060.
2. Kalantar-Zadeh K., Ikizler T.A., Block G., et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003, 42:864-881.
3. Mak R.H., Ikizler A.T., Kovesdy C.P., et al. Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle 2011, 2:9-25.
4. Fouque D., Kalantar-Zadeh K., Kopple J., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008, 73:391-398.
5. Kovesdy C.P., Kalantar-Zadeh K. Why is protein-energy wasting associated with mortality in chronic kidney disease?. Semin Nephrol 2009, 29:3-14.
6. Kalantar-Zadeh K., Kovesdy C.P., Derose S.F., et al. Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol 2007, 3:493-506.
7. Oreopoulos A., Padwal R., Kalantar-Zadeh K., et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156:13-22.
8. Oreopoulos A., Kalantar-Zadeh K., Sharma A.M., et al. The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med 2009, 25:643-659. viii.
9. Kalantar-Zadeh K., Block G., Horwich T., et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004, 43:1439-1444.
10. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005, 81:543-554.
11. Feroze U., Noori N., Kovesdy C.P., et al. Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status. Clin J Am Soc Nephrol 2011, 6:1100-1111.
12. Lacson E., Wang W., Hakim R.M., et al. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access. Am J Kidney Dis 2009, 53:79-90.
13. Beddhu S., Kaysen G.A., Yan G., et al. Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis 2002, 40:721-727.
14. Kalantar-Zadeh K., Kilpatrick R.D., Kuwae N., et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005, 20:1880-1888.
15. Lacson E., Ikizler T.A., Lazarus J.M., et al. Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs. J Ren Nutr 2007, 17:363-371.
16. Mehrotra R., Duong U., Jiwakanon S., et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis 2011, 58:418-428.
17. Molnar M.Z., Kovesdy C.P., Bunnapradist S., et al. Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant 2011, 11:1006-1015.
18. Rambod M., Kovesdy C.P., Bross R., et al. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 2008, 88:1485-1494.
19. Rambod M., Bross R., Zitterkoph J., et al. Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009, 53:298-309.
20. Shinaberger C.S., Greenland S., Kopple J.D., et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?. Am J Clin Nutr 2008, 88:1511-1518.
21. Kalantar-Zadeh K., Cano N.J., Budde K., et al. Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol 2011, 7:369-384.
22. Kalantar-Zadeh K. Why not meals during dialysis?. Ren Urol News 2009, 9:4.
23. Wizemann V. Regular dialysis treatment in Germany: the role of non-profit organisations. J Nephrol 2000, 13(suppl 3):S16-S19.
24. Pupim L.B., Majchrzak K.M., Flakoll P.J., et al. Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status. J Am Soc Nephrol 2006, 17:3149-3157.
25. Caglar K., Fedje L., Dimmitt R., et al. Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int 2002, 62:1054-1059.
26. Sundell M.B., Cavanaugh K.L., Wu P., et al. Oral protein supplementation alone improves anabolism in a dose-dependent manner in chronic hemodialysis patients. J Ren Nutr 2009, 19:412-421.
27. Kovesdy C.P., Kalantar-Zadeh K. Oral bicarbonate: renoprotective in CKD?. Nat Rev Nephrol 2010, 6:15-17.
28. Noori N., Kalantar-Zadeh K., Kovesdy C.P., et al. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol 2010, 5:683-692.
29. Noori N., Kalantar-Zadeh K., Kovesdy C.P., et al. Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis 2010, 56:338-347.
30. Szklarek-Kubicka M., Fijalkowska-Morawska J., Zaremba-Drobnik D., et al. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study. J Ren Nutr 2009, 19:487-493.
31. Moreira A.C., Gaspar A., Serra M.A., et al. Effect of a sardine supplement on C-reactive protein in patients receiving hemodialysis. J Ren Nutr 2007, 17:205-213.
32. Rattanasompattikul M., Molnar M.Z., Lee M.L., et al. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) Study: results of the pilot-feasibility double-blind randomized placebo-controlled trial. J Cachexia Sarcopenia Muscle 2013, [in press].
33. Lacson E., Wang W., Zebrowski B., et al. Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report. Am J Kidney Dis 2012, 60:591-600.
34. Cheu C., Pearson J., Dahlerus C., et al. Association between oral nutritional supplementation and clinical outcomes among patients with ESRD. Clin J Am Soc Nephrol 2012 Oct 18, [Epub ahead of print].
35. Koontz T., Balikian S., Bross R., et al. Fosrenol for Enhancing Dietary Protein Intake in Hypoalbuminemic Dialysis Patients (FrEDI) study. Kidney Res Clin Pract 2012, 31:A68. [abstract].
36. Potter J.M. Oral supplements in the elderly. Curr Opin Clin Nutr Metab Care 2001, 4:21-28.
37. Rammohan M., Kalantar-Zadeh K., Liang A., et al. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr 2005, 15:345-355.
38. Rodriguez Ayala E., Pecoits-Filho R., Heimburger O., et al. Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 2004, 19:421-426.
39. Riechelmann R.P., Burman D., Tannock I.F., et al. Phase II trial of mirtazapine for cancer-related cachexia and anorexia. Am J Hosp Palliat Care 2010, 27:106-110.
40. Pupim L.B., Flakoll P.J., Yu C., et al. Recombinant human growth hormone improves muscle amino acid uptake and whole-body protein metabolism in chronic hemodialysis patients. Am J Clin Nutr 2005, 82:1235-1243.
41. Goldberg R.M., Loprinzi C.L., Mailliard J.A., et al. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol 1995, 13:2856-2859.
42. Kovesdy C.P., Kalantar-Zadeh K. Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease. Expert Opin Investig Drugs 2008, 17:451-467.
43. Noori N., Dukkipati R., Kovesdy C.P., et al. Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. Am J Kidney Dis 2011, 58:248-256.
44. Dong J., Sundell M.B., Pupim L.B., et al. The effect of resistance exercise to augment long-term benefits of intradialytic oral nutritional supplementation in chronic hemodialysis patients. J Ren Nutr 2011, 21:149-159.
45. Pupim L.B., Flakoll P.J., Levenhagen D.K., et al. Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients. Am J Physiol Endocrinol Metab 2004, 286:E589-E597.
46. Ikizler T.A. Nutrition support for the chronically wasted or acutely catabolic chronic kidney disease patient. Semin Nephrol 2009, 29:75-84.
47. Dukkipati R., Kalantar-Zadeh K., Kopple J.D. Is there a role for intradialytic parenteral nutrition? A review of the evidence. Am J Kidney Dis 2010, 55:352-364.
48. Dezfuli A., Scholl D., Lindenfeld S.M., et al. Severity of hypoalbuminemia predicts response to intradialytic parenteral nutrition in hemodialysis patients. J Ren Nutr 2009, 19:291-297.
49. Ikizler T.A., Flakoll P.J., Parker R.A., et al. Amino acid and albumin losses during hemodialysis. Kidney Int 1994, 46:830-837.
50. Tayeb J.S., Provenzano R., El-Ghoroury M., et al. Effect of biocompatibility of hemodialysis membranes on serum albumin levels. Am J Kidney Dis 2000, 35:606-610.
51. Friedman A.N., Fadem S.Z. Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol 2010, 21:223-230.
52. Danielski M., Ikizler T.A., McMonagle E., et al. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis 2003, 42:286-294.
53. Kaysen G.A., Chertow G.M., Adhikarla R., et al. Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 2001, 60:333-340.
54. Pupim L.B., Flakoll P.J., Ikizler T.A. Nutritional supplementation acutely increases albumin fractional synthetic rate in chronic hemodialysis patients. J Am Soc Nephrol 2004, 15:1920-1926.
55. Kalantar-Zadeh K., Braglia A., Chow J., et al. An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: a pilot/feasibility study. J Ren Nutr 2005, 15:318-331.
56. Akpele L., Bailey J.L. Nutrition counseling impacts serum albumin levels. J Ren Nutr 2004, 14:143-148.
57. Leon J.B., Majerle A.D., Soinski J.A., et al. Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study. J Ren Nutr 2001, 11:9-15.
58. Bronich L., Te T., Shetye K., et al. Successful treatment of hypoalbuminemic hemodialysis patients with a modified regimen of oral essential amino acids. J Ren Nutr 2001, 11:194-201.
59. Eustace J.A., Coresh J., Kutchey C., et al. Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminemia. Kidney Int 2000, 57:2527-2538.
60. Kalantar-Zadeh K., Kopple J.D. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 2001, 38:1343-1350.
61. Kaysen G.A. Serum albumin concentration in dialysis patients: why does it remain resistant to therapy?. Kidney Int Suppl 2003, 1:S92-S98.
62. Miller J.E., Kovesdy C.P., Nissenson A.R., et al. Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis 2010, 55:100-112.